White Paper

How Curebase Helped A GI Therapeutic Study Increase Enrollment And Achieve FDA Clearance During COVID

Source: Curebase
Integrate Pharmaceutical Development For Commercialization Of Novel Therapeutics

Discover how Curebase and metaMe Health successfully completed an IBS digital therapeutic treatment study at the peak of global COVID-19 transmission by implementing direct-to-patient and clinician-driven recruitment strategies from diverse geographies across the United States.

In this white paper you’ll discover:

  • How Curebase’s eClinical software suite provided a customized single solution to remotely manage all aspects of trial, from recruitment through close-out.
  • The impact of Curebase’s rapid virtual site activation on increasing site onboarding and enrollment.
  • How Curebase’s virtual research staff maintained data quality through eConsent, ePROs, remote oversight, and real-time patient support.
  • Why Curebase’s end-to-end virtual research organization management was critical in delivering FDA-grade clinical research for metaMe.
access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader